As healthcare providers, our understanding of neurodegenerative disorders is continually evolving, and Parkinson's Disease (PD) is no exception. This article provides a comprehensive overview of PD, its pathophysiology, clinical manifestations, diagnosis, and treatment options.
PD is primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to an imbalance in the dopaminergic and cholinergic systems. The accumulation of α-synuclein, forming Lewy bodies, is a significant hallmark of the disease.
PD presents a range of motor symptoms such as bradykinesia, rigidity, and tremors. Non-motor symptoms like cognitive impairment, mood disorders, and autonomic dysfunction are also prevalent. The disease progression varies significantly among patients.
Diagnosis is primarily clinical, based on patient history and neurological examination. Currently, no definitive diagnostic test exists for PD; however, neuroimaging techniques like DaTSCAN can support the diagnosis.
Treatment for PD is symptomatic and aims to manage motor and non-motor symptoms. Levodopa remains the most effective treatment for motor symptoms. Deep Brain Stimulation (DBS) is another treatment modality for patients with advanced PD.
Research is ongoing to develop disease-modifying therapies for PD. These include neuroprotective agents, immunotherapies targeting α-synuclein, and regenerative therapies like stem cell transplantation.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its pathophysiology, clinical manifestations, and treatment options is crucial for providing comprehensive care. As medical professionals, we must stay abreast of the latest research to effectively manage and potentially alter the course of this debilitating disease.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation